Literature DB >> 15093881

Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

Kamyar Kalantar-Zadeh1, Gladys Block, Tamara Horwich, Gregg C Fonarow.   

Abstract

Traditional risk factors of a poor clinical outcome and mortality in the general population, including body mass index (BMI), serum cholesterol, and blood pressure (BP), are also found to relate to outcome in patients with chronic heart failure (CHF), but in an opposite direction. Obesity, hypercholesterolemia, and high values of BP have been demonstrated to be associated with greater survival among CHF patients. These findings are in contrast to the well-known associations of over-nutrition, hypercholesterolemia, and hypertension with a poor outcome in the general population. The association between traditional cardiovascular risk factors and an adverse clinical outcome in CHF patients is referred to as "reverse epidemiology." The mechanisms for this inverse association in CHF is not clear. There are other populations with a similar risk factor reversal phenomenon, including patients with end-stage renal disease receiving dialysis, those with advanced malignancies, and individuals with advanced age. Several possible causes are hypothesized: the time discrepancy of the competing risk factors may play a role; the presence of the "malnutrition-inflammation complex syndrome" in CHF patients may explain the existence of reverse epidemiology; and a decreased level of lipoprotein molecules may distort their endotoxin-scavenging role, predisposing CHF patients with a low serum cholesterol level to inflammatory consequences of endotoxemia. It is possible that new goals for such traditional risk factors as BMI, serum cholesterol, and BP should be developed for CHF. Reverse epidemiology of conventional cardiovascular risk factors is observed in CHF and may have a bearing on the management of these patients; thus, it deserves further investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15093881     DOI: 10.1016/j.jacc.2003.11.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  166 in total

1.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Metabolic syndrome and quality of life in the elderly: age and gender differences.

Authors:  Alice Laudisio; Emanuele Marzetti; Livia Antonica; Francesco Pagano; Davide L Vetrano; Roberto Bernabei; Giuseppe Zuccalà
Journal:  Eur J Nutr       Date:  2012-03-11       Impact factor: 5.614

3.  Are people with normal radionuclide perfusion imaging studies better-off if they are obese?

Authors:  Farbod Raiszadeh; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

4.  Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox".

Authors:  Carl J Lavie; Richard V Milani; Hector O Ventura; Abel Romero-Corral
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

5.  Obesity and outcomes among patients with established atrial fibrillation.

Authors:  Afrooz Ardestani; Heather J Hoffman; Howard A Cooper
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

6.  Stroke and the "stroke belt" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variation.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind A Phadnis; Sally K Rigler; John A Spertus; Xinhua Zhou; Purna Mukhopadhyay; Theresa I Shireman
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

7.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  To legitimize the contentious obesity paradox.

Authors:  Kamyar Kalantar-Zadeh; Connie M Rhee; Alpesh N Amin
Journal:  Mayo Clin Proc       Date:  2014-08       Impact factor: 7.616

Review 9.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

Review 10.  Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?

Authors:  Wolfram Doehner
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.